Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.

Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J.

Cancer Chemother Pharmacol. 2013 Mar;71(3):789-97. doi: 10.1007/s00280-013-2073-5. Epub 2013 Jan 22.

PMID:
23338051
2.

[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1].

Nemoto H, Sato T, Rino Y, Uchiyama M, Atsumi Y, Hasegawa S, Tamagawa H, Oshima T, Yukawa N, Yoshikawa T, Imada T, Masuda M.

Gan To Kagaku Ryoho. 2013 Sep;40(9):1221-4. Review. Japanese.

PMID:
24047784
3.

[Curative resection for Stage IV advanced gastric cancer that responded to combination chemotherapy with docetaxel, cisplatin, and S-1].

Nishiuchi A, Nishino H, Kato S, Kadokawa Y, Machimoto T, Asao Y, Furuyama H, Yoshimura T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2305-7. Review. Japanese.

PMID:
25731504
4.

[Three cases of advanced gastric cancer successfully treated by combination therapy of biweekly S-1 and docetaxel].

Numata M, Oshima T, Amano S, Fukahori M, Godai T, Sato T, Makino H, Fujii S, Rino Y, Masuda M, Imada T, Kunisaki C.

Gan To Kagaku Ryoho. 2011 Mar;38(3):443-8. Review. Japanese.

PMID:
21403451
5.

[Combination chemotherapy of S-1 plus biweekly docetaxel for advanced and recurrent gastric cancer].

Takahashi I, Oki E, Egashira A, Morita M, Kakeji Y, Maehara Y.

Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:87-90. Review. Japanese.

PMID:
16897979
6.

[S-1 for gastric cancer-S-1 monotherapy and its progress].

Shitara K, Sakata Y, Kudou T, Munakata M.

Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:43-51. Review. Japanese.

PMID:
16897971
7.

[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin].

Fujino M, Kametaka H, Makino H, Yokoyama M, Matsuo M, Seike K, Koyama T, Hasegawa A.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2238-40. Review. Japanese.

PMID:
24394071
8.

[Combination chemotherapy of TS-1 and docetaxel on advanced and recurrent gastric cancer].

Yoshida K, Toge T.

Gan To Kagaku Ryoho. 2004 Nov;31(12):1982-6. Review. Japanese.

PMID:
15570925
9.

Applications of genomics in NSCLC.

Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O.

Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Review.

PMID:
16557672
10.

[Progress in chemotherapy for advanced gastric cancer].

Xu RH, Teng KY.

Ai Zheng. 2009 Oct;28(10):1108-13. Review. Chinese.

PMID:
19799823
11.

[Chemotherapy for gastric cancer].

Baba H, Kakeji Y, Oki E, Tokunaga E, Ushiro S, Watanabe M, Maehara Y.

Gan To Kagaku Ryoho. 2003 Nov;30(12):1881-8. Review. Japanese.

PMID:
14650954
12.

[A case of advanced gastric cancer with carcinomatous lymphangitis of the lung treated with docetaxel and S-1 combination chemotherapy].

Okamoto E, Takagi K, Tamura A, Kondo M, Hanada S, Sakuranaka H, Ochi J, Tanaka M, Tei S, Ichioka M, Shibayama T.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2247-9. Review. Japanese.

PMID:
24394074
13.

[Docetaxel and gastric cancer].

Ducreux M, Boige V, Roth A.

Bull Cancer. 2004 Mar;91(3):257-61. Review. French.

14.

Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.

Ajani JA.

Expert Opin Pharmacother. 2006 Aug;7(12):1627-31. Review.

PMID:
16872265
15.

Docetaxel in advanced gastric cancer--review of the main clinical trials.

Di Cosimo S, Ferretti G, Fazio N, Silvestris N, Carlini P, Alimonti A, Gelibter A, Felici A, Papaldo P, Cognetti F.

Acta Oncol. 2003;42(7):693-700. Review.

PMID:
14690154
16.

[Clinical development of chemotherapy for advanced gastric cancer].

Sato A, Matsukawa M.

Nihon Shokakibyo Gakkai Zasshi. 2007 Feb;104(2):186-93. Review. Japanese. No abstract available.

PMID:
17283412
17.

[CPT-11 combined chemotherapy for metastatic gastric cancer].

Narahara H, Sugimoto N, Iishi H, Tatsuta M.

Gan To Kagaku Ryoho. 2004 Nov;31(12):1973-7. Review. Japanese.

PMID:
15570923
18.

WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer.

Wu AW, Xu GW, Wang HY, Ji JF, Tang JL.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005047. Review.

PMID:
17943834
19.

Neoadjuvant chemotherapy versus none for resectable gastric cancer.

Wu AW, Xu GW, Wang HY, Ji JF, Tang JL.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005047. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD005047.

PMID:
17443566
20.

The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for human use (CHMP).

Matt P, van Zwieten-Boot B, Calvo Rojas G, Ter Hofstede H, Garcia-Carbonero R, Camarero J, Abadie E, Pignatti F.

Oncologist. 2011;16(10):1451-7. doi: 10.1634/theoncologist.2011-0224. Epub 2011 Sep 30. Review.

Supplemental Content

Support Center